Publications

Kulpa, J., Harrison, A., Rudolph, L., Eglit, G. M. L., Turcotte, C., Bonn-Miller, M. O., & Peters, E. N. (2023). Oral cannabidiol treatment in two postmenopausal women with osteopenia: a case series. Cannabis and Cannabinoid Research, 8(S1), S83–S89. 

Moore, C. F., Weerts, E. M., Kulpa, J., Schwotzer, D., Dye, W., Jantzi, J., McDonald, J. D., Lefever, T. W., & Bonn-Miller, M. O. (2023). Pharmacokinetics of oral minor cannabinoids in blood and brain. Cannabis and Cannabinoid Research, 8(S1), S51–S61.

Kulpa, J., Henderson, R. G., Schwotzer, D., Dye, W., Trexler, K. R., McDonald, J., Lefever, T. W., & Bonn-Miller, M. O. (2023). Toxicological evaluation and pain assessment of four minor cannabinoids following 14-day oral administration in rats. Cannabis and Cannabinoid Research, 8(S1), S25–S41.

Kulpa, J., Lefever, T. W., Trexler, K. R., Henderson, R. G., Macnair, L., Toth, M. L., Vanapalli, S. A., Rahman, M., Gupta, S., & Bonn-Miller, M. O. (2023). Toxicity of cannabigerol: Examination of long-term toxicity and lifespan in Caenorhabditis elegans and 14-day study in Sprague Dawley rats. Cannabis and Cannabinoid Research, 8, S62–S70. 

MacNair, L., Kulpa, J., Hill, M. L., Eglit, G. M. L., Mosesova, I., Bonn-Miller, M. O., & Peters, E. N. (2023). Sex differences in the pharmacokinetics of cannabidiol and metabolites following oral administration of a cannabidiol-dominant cannabis oil in healthy adults. Cannabis and Cannabinoid Research, 10.1089/can.2022.0345. Advance online publication.

Schwotzer, D., Kulpa, J., Trexler, K., Dye, W., Jantzi, J., Irshad, H., Ware, M. A., Bonn-Miller, M., McDonald, J., & Lefever, T. (2023). Pharmacokinetics of cannabidiol in Sprague-Dawley rats after oral and pulmonary administration. Cannabis and Cannabinoid Research, 8(2), 360–373. 

Irshad, H., Kulpa, J., Kuehl, P. J., Lefever, T., & McDonald, J. D. (2023). Characterization of aerosols from hemp-derived pre-roll joints. Inhalation Toxicology, 35(5-6), 169–174. doi: 10.1080/08958378.2023.2206448

Peters, E. N., MacNair, L., Mosesova, I., Christians, U., Sempio, C., Klawitter, J., Land M.H., Ware M.A., Turcotte C., & Bonn-Miller, M. O. (2022). Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ 9-tetrahydrocannabinol: a pilot study. European Journal of Clinical Pharmacology, 1-7.

Peters, E. N., Mosesova, I., MacNair, L., Vandrey, R., Land, M. H., Ware, M. A., Turcotte, C. & Bonn-Miller, M. O. (2022). Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Parsticipants. Journal of Analytical toxicology, 46(5), 528-539.

Peters, E. N., Mosesova, I., MacNair, L., Vandrey, R., Land, M. H., Ware, M. A., Turcotte, C. & Bonn-Miller, M. O. (2022). Safety, pharmacokinetics and pharmacodynamics of spectrum yellow oil in healthy participants. Journal of Analytical Toxicology, 46(4), 393-407.

Kulpa, J., Eglit, G., Hill, M. L., MacNair, L., Yardley, H., Ware, M. A., Bonn-Miller, M. O., & Peters, E. N. (2022). Serum markers of bone turnover following controlled administration of two medical cannabis products in healthy adults. Cannabis and Cannabinoid Research, 10.1089/can.2022.0181. Advance online publication.

Anderson, L. L., Etchart, M. G., MacNair, L., Land, M. H., Mosesova, I. A., Bonn-Miller, M. O., & Arnold, J. C. (2022). In vitro screening of three commercial cannabis-based products on ATP-binding cassette and solute-carrier transporter function. Cannabis and Cannabinoid Research, 7(3), 304-317.

Mödinger, Y., Knaub, K., Dharsono, T., Wacker, R., Meyrat, R., Land, M.H., Petraglia, A.L. and Schön, C., (2022). Enhanced Oral Bioavailability of β-Caryophyllene in Healthy Subjects Using the VESIsorb® Formulation Technology, a Novel Self-Emulsifying Drug Delivery System (SEDDS). Molecules, 27(9), p.2860.

Vaughn, D., Paulionis, L., & Kulpa, J. (2021). Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs. American Journal of Veterinary Research, 82(5), 405–416.

Kulpa, J., Paulionis, L., Eglit, G., & Vaughn, D. (2021). Safety and tolerability of escalating cannabinoid doses in healthy cats. Journal of Feline Medicine and Surgery.

Land, M. H., Toth, M. L., MacNair, L., Vanapalli, S. A., Lefever, T. W., Peters, E. N., & Bonn-Miller, M. O. (2021). Effect of cannabidiol on the long-term toxicity and lifespan in the preclinical model Caenorhabditis elegans. Cannabis and Cannabinoid Research, 6(6), 522-527.

Szaflarski, M., McGoldrick, P., Currens, L., Blodgett, D., Land, H., Szaflarski, J. P., & Segal, E. (2020). Attitudes and knowledge about cannabis and cannabis-based therapies among US neurologists, nurses, and pharmacists. Epilepsy & Behavior, 109, 107102.

Vaughn, D., Kulpa, J., & Paulionis, L. (2020). Preliminary investigation of the safety of escalating cannabinoid doses in healthy dogs. Frontiers in Veterinary Science, 7, 51.

Land, M. H., MacNair, L., Thomas, B. F., Peters, E. N., & Bonn-Miller, M. O. (2020). Letter to the Editor: Possible drug–drug interactions between cannabinoids and candidate COVID-19 drugs. Cannabis and Cannabinoid Research, 5(4), 340-343.

Mendoza-Sanchez, R., Cotnoir-White, D., Kulpa, J., Jutras, I., Pottel, J., Moitessier, N., Mader, S., & Gleason, J. L. (2015). Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids. Bioorganic & Medicinal Chemistry, 23(24), 7597–7606. 

Kulpa, J., Chinnappareddy, N., & Pyle, W. G. (2012). Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha. PloS One, 7(7), e41076. 

Shaw, E. E., Wood, P., Kulpa, J., Yang, F. H., Summerlee, A. J., & Pyle, W. G. (2009). Relaxin alters cardiac myofilament function through a PKC-dependent pathway. American Journal of Physiology. Heart and Circulatory Physiology, 297(1), H29-36.